Pfizer-QB3 Drug-Discovery Pact Moving Forward Despite Minor Snags

Approximately one year after Pfizer and the California Institute for Quantitative Biosciences inked a three-year, $9.5 million drug-discovery pact, the alliance is now overseeing seven projects combining scientists from various Pfizer sites and QB3-affiliated researchers at UC-San Francisco.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.